X4 Pharmaceuticals, Inc. (XFOR)

NASDAQ: XFOR · IEX Real-Time Price · USD

1.150

+0.070 (6.48%)

At close: May 3, 2024, 4:00 PM

1.130

-0.020 (-1.74%)

After-hours: May 3, 2024, 7:59 PM EDT

X4 Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018	2017	2016	2015
Market Capitalization	193	140	69	57	105	133	33	175	-	-
Market Cap Growth	-	104.03%	21.51%	-45.97%	-21.43%	301.31%	-80.99%	-	-	-
Enterprise Value	137	84	-15	15	64	30	35	110	12	0
PE Ratio	-1.39	-1.39	-0.71	-0.55	-1.69	-2.50	-0.91	-6.99	-	-
PS Ratio	-	-	-	-	34.91	-	-	-	-	-
PB Ratio	3.78	2.75	0.93	0.88	1.44	1.03	-0.43	2.98	-	-
P/FCF Ratio	-1.45	-1.45	-0.89	-0.79	-1.74	-2.76	-1.31	-8.06	-	-
P/OCF Ratio	-1.45	-1.45	-0.89	-0.80	-1.78	-2.77	-1.31	-8.20	-	-
EV/Sales Ratio	-	-	-	-	21.49	-	-	-	-	-
EV/EBITDA Ratio	-0.90	-0.90	0.17	-0.18	-1.11	-0.60	-1.08	-5.12	-0.59	-0.01
EV/EBIT Ratio	-0.88	-0.88	0.16	-0.17	-1.09	-0.59	-1.07	-5.11	-0.58	-0.01
EV/FCF Ratio	-0.87	-0.87	0.19	-0.20	-1.07	-0.62	-1.37	-5.06	-0.55	-0.01
Debt / Equity Ratio	1.14	1.14	0.52	0.62	0.53	0.18	-0.13	0.21	-0.27	-0.21
Debt / EBITDA Ratio	-0.62	-0.62	-0.44	-0.48	-0.66	-0.46	-0.30	-0.57	-0.76	-0.58
Debt / FCF Ratio	-0.60	-0.60	-0.50	-0.56	-0.64	-0.48	-0.39	-0.56	-0.70	-0.65
Quick Ratio	5.02	5.02	5.50	5.89	6.66	13.57	1.03	7.37	0.40	1.29
Current Ratio	5.34	5.34	5.76	6.27	6.97	13.69	1.18	7.45	0.47	1.26
Asset Turnover	0	0	0	0	0.02	0	0	0	0	-
Interest Coverage	-16.50	-16.50	-22.50	-23.35	-22.06	-23.60	-45.23	-43.89	-8.14	-27.00
Return on Equity (ROE)	-170.10%	-170.10%	-178.80%	-126.10%	-64.40%	-64.00%	-392.50%	-2330.40%	50.60%	-
Return on Assets (ROA)	-65.40%	-65.40%	-85.80%	-76.00%	-45.00%	-45.80%	-79.70%	-56.30%	-268.80%	-
Return on Capital (ROIC)	-98.30%	-98.30%	-77.86%	-81.68%	-53.82%	-33.99%	43.25%	-31.36%	58.99%	54.65%
Earnings Yield	-52.38%	-72.12%	-140.24%	-181.40%	-59.33%	-40.06%	-109.32%	-14.30%	-	-
FCF Yield	-50.00%	-68.85%	-112.30%	-126.40%	-57.47%	-36.19%	-76.54%	-12.41%	-	-
Buyback Yield / Dilution	-179.91%	-179.91%	-146.71%	-28.25%	-74.13%	-2411.98%	-0.22%	-435.12%	-0.96%	-
Total Shareholder Return	-179.91%	-179.91%	-146.71%	-28.25%	-74.13%	-2411.98%	-0.22%	-435.12%	-0.96%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).